Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro‐esophageal junction from a tertiary cancer care center in India-Reference-Cited by-同舟云学术

Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro‐esophageal junction from a tertiary cancer care center in India

Published:2021-03-02 Issue:7 Volume:123 Page:1547-1557
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Rao T. Subramanyeshwar¹^ORCID,Raju Kalidindi Venkata Vijaya Narsimha¹^ORCID,Patnaik Sujit Chyau¹^ORCID,Reddy Pratap¹^ORCID,Saksena Ajesh Raj¹^ORCID,Rajappa Senthil²,Mallavarapu Krishna Mohan²,Santa Ayyagari²,Gudipudi Deleep³^ORCID,Boleneni Naren¹^ORCID,Usofi Zeeba¹^ORCID,Gujjuru Swathi⁴,Smith Lynette⁵,Are Chandrakanth⁶^ORCID,Nusrath Syed¹^ORCID

Affiliation:

1. Department of Surgical Oncology Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad Telangana India

2. Department of Medical Oncology Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad Telangana India

3. Department of Radiation Oncology Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad Telangana India

4. Department of Clinical research and trials Basavatarakam Indo American Cancer Hospital and Research Institute Hyderabad Telangana India

5. Department of Biostatistics, College of Public Health University of Nebraska Medical Center Omaha Nebraska USA

6. Department of Surgery University of Nebraska Medical Center Omaha Nebraska USA

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26444

Reference24 articles.

1. Esophagus cancer fact sheet. IARC Lyons France. 2018 (Cited 01‐12‐2019). Available fromhttps://gco.iarc.fr/today/data/factsheets/cancers/6-Oesophagus-fact-sheet.pdf

2. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

3. Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

4. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

5. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort;The British Journal of Radiology;2023-02

2. Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction;Journal of Surgical Oncology;2022-09-21

3. At crossroads with CROSS: Implementing the CROSS protocol in a resource-limited setting;Cancer Research, Statistics, and Treatment;2021